指紋
查看啟用 急重症醫學研究所 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
過去五年中的合作和熱門研究領域
國家/地區層面的近期外部共同作業。按一下圓點深入探索詳細資料，或
-
Cefiderocol versus standard therapy for hospital-acquired and health-care-associated Gram-negative bacterial bloodstream infection (the GAME CHANGER trial): an open-label, parallel-group, randomised trial
GAME CHANGER Trial Investigators, 2月 2026, 於: The Lancet Infectious Diseases. 26, 2, p. 148-159 12 p.研究成果: Article › 同行評審
12 引文 斯高帕斯（Scopus） -
Change in dapagliflozin trial eligibility status and prognosis among patients with acute heart failure with preserved ejection fraction
Ling, L. C., Huang, W. M., Chang, H. C., Lee, C. W., Yu, W. C., Cheng, H. M., Chiang, C. E., Chen, C. H. & Sung, S. H., 3 2月 2026, 於: Journal of the Chinese Medical Association. Publish Ahead of Print研究成果 › 同行評審
開啟存取 -
Classification of hematologic malignancies from whole-slide bone marrow aspirates using a two-stage deep convolutional neural network pipeline
Chen, H. R., Liu, Y. C., Yeh, C. M., Lin, C. K., Chien, T. Y., Hong, Y. C., Liu, C. J. & Yu, K. H., 1 1月 2026, 於: Digital Health. 12研究成果 › 同行評審
開啟存取